Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients.
<h4>Background and purpose</h4>Xanthine oxidoreductase (XOR), which catalyzes purine catabolism, has two interconvertible forms, xanthine dehydrogenase and xanthine oxidase, the latter of which produces superoxide during uric acid (UA) synthesis. An association between plasma XOR activit...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0182699&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850229107168641024 |
|---|---|
| author | Yuki Fujimura Yohei Yamauchi Takayo Murase Takashi Nakamura Shu-Ichi Fujita Tomohiro Fujisaka Takahide Ito Koichi Sohmiya Masaaki Hoshiga Nobukazu Ishizaka |
| author_facet | Yuki Fujimura Yohei Yamauchi Takayo Murase Takashi Nakamura Shu-Ichi Fujita Tomohiro Fujisaka Takahide Ito Koichi Sohmiya Masaaki Hoshiga Nobukazu Ishizaka |
| author_sort | Yuki Fujimura |
| collection | DOAJ |
| description | <h4>Background and purpose</h4>Xanthine oxidoreductase (XOR), which catalyzes purine catabolism, has two interconvertible forms, xanthine dehydrogenase and xanthine oxidase, the latter of which produces superoxide during uric acid (UA) synthesis. An association between plasma XOR activity and cardiovascular and renal outcomes has been previously suggested. We investigated the potential association between cardiac parameters and plasma XOR activity among cardiology patients.<h4>Methods and results</h4>Plasma XOR activity was measured by [13C2,15N2]xanthine coupled with liquid chromatography/triplequadrupole mass spectrometry. Among 270 patients who were not taking UA-lowering drugs, XOR activity was associated with body mass index (BMI), alanine aminotransferase (ALT), HbA1c and renal function. Although XOR activity was not associated with serum UA overall, patients with chronic kidney disease (CKD), those with higher XOR activity had higher serum UA among patients without CKD. Compared with patients with the lowest XOR activity quartile, those with higher three XOR activity quartiles more frequently had left ventricular hypertrophy. In addition, plasma XOR activity showed a U-shaped association with low left ventricular ejection fraction (LVEF) and increased plasma B-type natriuretic peptide (BNP) levels, and these associations were independent of age, gender, BMI, ALT, HbA1C, serum UA, and CKD stages.<h4>Conclusions</h4>Among cardiac patients, left ventricular hypertrophy, low LVEF, and increased BNP were significantly associated with plasma XOR activity independent of various confounding factors. Whether pharmaceutical modification of plasma XOR activity might inhibit cardiac remodeling and improve cardiovascular outcome should be investigated in future studies. |
| format | Article |
| id | doaj-art-0a521377338c4aa68d826476d399c8a0 |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-0a521377338c4aa68d826476d399c8a02025-08-20T02:04:20ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01128e018269910.1371/journal.pone.0182699Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients.Yuki FujimuraYohei YamauchiTakayo MuraseTakashi NakamuraShu-Ichi FujitaTomohiro FujisakaTakahide ItoKoichi SohmiyaMasaaki HoshigaNobukazu Ishizaka<h4>Background and purpose</h4>Xanthine oxidoreductase (XOR), which catalyzes purine catabolism, has two interconvertible forms, xanthine dehydrogenase and xanthine oxidase, the latter of which produces superoxide during uric acid (UA) synthesis. An association between plasma XOR activity and cardiovascular and renal outcomes has been previously suggested. We investigated the potential association between cardiac parameters and plasma XOR activity among cardiology patients.<h4>Methods and results</h4>Plasma XOR activity was measured by [13C2,15N2]xanthine coupled with liquid chromatography/triplequadrupole mass spectrometry. Among 270 patients who were not taking UA-lowering drugs, XOR activity was associated with body mass index (BMI), alanine aminotransferase (ALT), HbA1c and renal function. Although XOR activity was not associated with serum UA overall, patients with chronic kidney disease (CKD), those with higher XOR activity had higher serum UA among patients without CKD. Compared with patients with the lowest XOR activity quartile, those with higher three XOR activity quartiles more frequently had left ventricular hypertrophy. In addition, plasma XOR activity showed a U-shaped association with low left ventricular ejection fraction (LVEF) and increased plasma B-type natriuretic peptide (BNP) levels, and these associations were independent of age, gender, BMI, ALT, HbA1C, serum UA, and CKD stages.<h4>Conclusions</h4>Among cardiac patients, left ventricular hypertrophy, low LVEF, and increased BNP were significantly associated with plasma XOR activity independent of various confounding factors. Whether pharmaceutical modification of plasma XOR activity might inhibit cardiac remodeling and improve cardiovascular outcome should be investigated in future studies.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0182699&type=printable |
| spellingShingle | Yuki Fujimura Yohei Yamauchi Takayo Murase Takashi Nakamura Shu-Ichi Fujita Tomohiro Fujisaka Takahide Ito Koichi Sohmiya Masaaki Hoshiga Nobukazu Ishizaka Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients. PLoS ONE |
| title | Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients. |
| title_full | Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients. |
| title_fullStr | Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients. |
| title_full_unstemmed | Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients. |
| title_short | Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients. |
| title_sort | relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0182699&type=printable |
| work_keys_str_mv | AT yukifujimura relationshipbetweenplasmaxanthineoxidoreductaseactivityandleftventricularejectionfractionandhypertrophyamongcardiacpatients AT yoheiyamauchi relationshipbetweenplasmaxanthineoxidoreductaseactivityandleftventricularejectionfractionandhypertrophyamongcardiacpatients AT takayomurase relationshipbetweenplasmaxanthineoxidoreductaseactivityandleftventricularejectionfractionandhypertrophyamongcardiacpatients AT takashinakamura relationshipbetweenplasmaxanthineoxidoreductaseactivityandleftventricularejectionfractionandhypertrophyamongcardiacpatients AT shuichifujita relationshipbetweenplasmaxanthineoxidoreductaseactivityandleftventricularejectionfractionandhypertrophyamongcardiacpatients AT tomohirofujisaka relationshipbetweenplasmaxanthineoxidoreductaseactivityandleftventricularejectionfractionandhypertrophyamongcardiacpatients AT takahideito relationshipbetweenplasmaxanthineoxidoreductaseactivityandleftventricularejectionfractionandhypertrophyamongcardiacpatients AT koichisohmiya relationshipbetweenplasmaxanthineoxidoreductaseactivityandleftventricularejectionfractionandhypertrophyamongcardiacpatients AT masaakihoshiga relationshipbetweenplasmaxanthineoxidoreductaseactivityandleftventricularejectionfractionandhypertrophyamongcardiacpatients AT nobukazuishizaka relationshipbetweenplasmaxanthineoxidoreductaseactivityandleftventricularejectionfractionandhypertrophyamongcardiacpatients |